PPARgamma agonists sensitize PTEN‐deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Pharmacology"
DOI: 10.1016/j.ejphar.2018.01.036
Abstract: Abstract We aimed to develop novel drug combination strategy to overcome drug resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in the treatment of non‐small cell lung cancer (NSCLC). Peroxisome proliferator‐activated receptor… read more here.
Keywords: ppar ggr; ggr agonists; ggr; lung cancer ... See more keywords